US Pharma MarketingThe post GT Medical Technologies raises $100m for brain tumour therapy advance appeared first on Medical Device Network.
GT Medical Technologies raises $100m for brain tumour therapy advance
GT Medical Technologies recently presented final data from a Phase III study of its GammaTile radiation therapy versus the SoC at this year’s ASCO meeting. GT Medical Technologies recently presented final data from a Phase III study of its GammaTile radiation therapy versus the SoC at this year’s ASCO meeting. GT Medical’s GammaTile is designed to deliver targeted radiation to the tumour resection site when cancer cells are at their lowest residual levels. Credit: crystal light / Shutterstock.com GT Medical Technologies has raised $100m to advance its radiation therapy implant for treating brain tumours. The Arizona-based company’s oversubscribed Series E…
GT Medical Technologies recently presented final data from a Phase III study of its GammaTile radiation therapy versus the SoC at this year’s ASCO meeting.
Source: Medical Device Network